The Landscape of Using Glycosyltransferase Gene Signatures for Overall Survival Prediction in Hepatocellular Carcinoma

Figure 3

Validation of four-gene signature in the validation set of TCGA database. (a, b) The distribution of the risk score, overall survival (OS), and survival status in the validation set of TCGA cohort. (c) Kaplan–Meier analysis to compare OS between patients with HCC in high- and low-risk groups in the validation set. (d) Receiver operating characteristic analysis of the 4-gene signature for predicting the OS in the validation set of TCGA database.

(a)

(b)

(c)

(d)